RTSN
Retension Pharmaceuticals, Inc. · Healthcare
Insiders bought $370K of Retension Pharmaceuticals, Inc. in the last 12 months
2 insiders bought on 1 day.
RTSN over the last year
Prices for RTSN aren't in yet.
Largest buyers, last 12 months
RTSN after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
2 insider filings since 2026, newest first
About Retension Pharmaceuticals, Inc.
Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling. The company was incorporated in 2023 and is headquartered in Falls Church, Virginia.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.